Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017306
Filing Date
2019-05-08
Accepted
2019-05-08 17:01:45
Documents
81
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20190331.htm 10-Q 1597413
2 EX-10.1 prtk-ex101_211.htm EX-10.1 60560
3 EX-10.2 prtk-ex102_424.htm EX-10.2 1812337
4 EX-31.1 prtk-ex311_8.htm EX-31.1 18167
5 EX-31.2 prtk-ex312_6.htm EX-31.2 18316
6 EX-32.1 prtk-ex321_9.htm EX-32.1 6525
7 EX-32.2 prtk-ex322_7.htm EX-32.2 6409
  Complete submission text file 0001564590-19-017306.txt   9387229

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT prtk-20190331.xml EX-101.INS 1581494
9 XBRL TAXONOMY EXTENSION SCHEMA prtk-20190331.xsd EX-101.SCH 77515
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20190331_cal.xml EX-101.CAL 58049
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20190331_def.xml EX-101.DEF 244675
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20190331_lab.xml EX-101.LAB 545710
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20190331_pre.xml EX-101.PRE 397001
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 19807501
SIC: 2834 Pharmaceutical Preparations